Premium Information is available for this item - Upgrade for $1 a day
6505-00-074-4104
Hydrochlorothiazide And Reserpine Tablets
6505000744104 000744104 HYDR0PRES
January 2023
4
Marketplace 6505-00-074-4104
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-074-4104 4+ Documents (More...)
Hydrochlorothiazide And Reserpine Tablets CQCT]Bottle NATO Stock Numbers Related to 6505-00-074-4104
6505-21-846-1971 6505-00-074-4104 6505-33-189-9378 https//www.nsnlookup.com /cage Basf Espanola
Numbers Related to 6505-33-189-9378 6505-21-846-1971 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-074-4104
Reserpine Tablets 100.000 TabletsPrimary Container Type [CQCT]Bottle NATO Stock Numbers Related to 6505-00-074-4104
Restrictions 6505-00-074-4104
6505-00-074-4104 is a Hydrochlorothiazide And Reserpine Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-00-074-4104
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-074-4104
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-074-4104
- Part Number
- Manufacturer
- Status
- HYDR0PRES
- Manufacturer
- 06990 - Merck Sharp & Dohme Corp. (Active)
- Incomplete Reference
- Incomplete Reference
Datasheet 6505-00-074-4104
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 50.000 Milligrams Hydrochlorothiazide Active Ingredient And 0.125 Milligrams Reserpine Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Primary Container Type [CQCT]
- Bottle
NATO Stock Numbers Related to 6505-00-074-4104
Freight Information 6505-00-074-4104
6505-00-074-4104 has freight characteristics.. 6505-00-074-4104 has a variance between NMFC and UFC when transported by rail and the description should be consulted.